# Dysregulation of store-operated calcium entry in fibroblast lines from adult and juvenile-onset Huntington’s disease patients

**Authors:** Samuel Oluwafemi Egbuwalo, Ewelina Latoszek, Hana Hansíková, Jiří Klempíř, Alžbeta Mühlbäck, Georg Bernhard Landwehrmeyer, Jacek Kuźnicki, Magdalena Czeredys

PMC · DOI: 10.1007/s43440-025-00820-8 · 2026-01-20

## TL;DR

This study shows that calcium entry in fibroblasts from Huntington’s disease patients is dysregulated differently in adult- and juvenile-onset cases, independent of genetic repeat length.

## Contribution

The study reveals distinct SOCE dysregulation in fibroblasts from adult- and juvenile-onset HD patients, independent of CAG repeat length.

## Key findings

- Adult-onset HD fibroblasts show increased SOC channel activity compared to controls.
- Juvenile-onset HD fibroblasts exhibit reduced SOC channel activity compared to controls.
- SOCE dysregulation in HD fibroblasts is independent of CAG repeat length.

## Abstract

The pathology of Huntington’s disease (HD) is marked by the aggregation of mutant huntingtin protein (mHTT), which results from expanded polyglutamine (polyQ) residues encoded by CAG repeats in the HTT gene. These repeats are differentially elongated in adult- and juvenile-onset HD. In striatal neurons, the mHTT disrupts cellular mechanisms such as store-operated calcium entry (SOCE), a process in which endoplasmic reticulum Ca²⁺ depletion triggers extracellular Ca²⁺ influx; however, this process can also be affected in peripheral cells. The aim of this study was to evaluate SOCE in fibroblasts derived from both HD onset patients and age-related controls.

We conducted SOCE analysis in dermal fibroblasts from 12 HD patients (including adult- and juvenile-onset subtypes) and age-related healthy controls using Fura-2 AM ratiometric imaging paired with EGTA-based extracellular calcium chelation protocols. To evaluate SOCE response, we administered two SOC channel inhibitors, 6-bromo-N-(2-phenylethyl)-2,3,4,9-tetrahydro-1 H-carbazol-1-amine hydrochloride (C20H22BrClN2) and EVP4593, in premanifest HD fibroblasts.

In healthy human fibroblast lines, a decline in SOCE was observed between juvenile and adult individuals. In fibroblast lines from adult-onset HD patients (premanifest, early manifest, and manifest stages), we observed increased SOC channel activity. Conversely, juvenile-onset HD fibroblast lines exhibited reduced SOC channel activity compared to controls. Notably, SOCE dysregulation was independent of CAG repeat length in HD lines. Both SOC channel inhibitors attenuated SOCE in adult-onset HD lines.

The mHTT upregulates SOCE in adult-onset HD fibroblasts and downregulates it in juvenile-onset HD fibroblast lines; however, SOCE levels do not correlate with the length of CAG repeats encoding mHTT. Despite opposing trends compared to age-related controls, similar levels of SOCE in both HD-onset fibroblasts were detected. Both C20H22BrClN2 and EVP4593 show potential for stabilizing SOCE in adult-onset HD. These findings suggest that dysregulated SOCE could be investigated as a peripheral target for studying pathological processes potentially associated with Huntington’s disease.

## Linked entities

- **Genes:** HTT (huntingtin) [NCBI Gene 3064]
- **Chemicals:** EVP4593 (PubChem CID 509554), Fura-2 AM (PubChem CID 105091), EGTA (PubChem CID 6207)
- **Diseases:** Huntington’s disease (MONDO:0007739), HD (MONDO:0007739)

## Full-text entities

- **Genes:** HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}
- **Diseases:** HD (MESH:D006816)
- **Chemicals:** calcium (MESH:D002118), Fura-2 AM (MESH:C049925), 6-bromo-N-(2-phenylethyl)-2,3,4,9-tetrahydro-1 H-carbazol-1-amine hydrochloride (-), SOC (MESH:C001599), polyQ (MESH:C097188), EGTA (MESH:D004533), EVP4593 (MESH:C562064)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975840/full.md

---
Source: https://tomesphere.com/paper/PMC12975840